Atlas Venture
Simon Read is currently an Entrepreneur In Residence at Atlas Venture. He is also the Founder and CEO of Curie Therapeutics. Simon has served on the Board of Directors for TRIANA Biomedicines and the Scientific Advisory Board for Q32 Bio Inc.
Simon Read worked as Chief Scientific Officer at Ra Pharmaceuticals from 2016 to 2020. Prior to that, he was Vice President and Head of Innovative Medicines at Grünenthal from 2011 to 2016.
This person is not in any teams
Atlas Venture
Atlas Venture is a leading biotech venture capital firm. With the goal of doing well by doing good, they have been building breakthrough biotech startups since 1993. They work side by side with exceptional scientists and entrepreneurs to translate high impact science into medicines for patients. Their seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value.